United States v. Regenerative Sciences, LLC
United States District Court for the District of Columbia
878 F. Supp. 2d 248 (2012)
- Written by Alex Ruskell, JD
Facts
Regenerative Sciences, LLC (defendant) was a doctor-formed company that created a procedure using stem cells for orthopedic healing. The procedure involved a doctor taking a tissue sample from a patient, putting that sample in a solution to grow new cells, shipping the solution to a laboratory, having a doctor at the lab inspect the solution, and then ultimately reinjecting the solution back into the patient. The Food and Drug Administration (FDA) sued, arguing that the procedure fell within the meaning of a drug under the Food, Drug, and Cosmetics Act. The FDA claimed that the procedure resulted in an adulterated and misbranded drug. Regenerative responded that they practiced medicine wholly within Colorado and that the procedure was not a drug subject to federal regulation.
Rule of Law
Issue
Holding and Reasoning (Collyer, J.)
What to do next…
Here's why 806,000 law students have relied on our case briefs:
- Written by law professors and practitioners, not other law students. 46,300 briefs, keyed to 988 casebooks. Top-notch customer support.
- The right amount of information, includes the facts, issues, rule of law, holding and reasoning, and any concurrences and dissents.
- Access in your classes, works on your mobile and tablet. Massive library of related video lessons and high quality multiple-choice questions.
- Easy to use, uniform format for every case brief. Written in plain English, not in legalese. Our briefs summarize and simplify; they don’t just repeat the court’s language.